Skip to content
Subscriber Only

Novartis Malaria Drug May Yield First New Treatment in 30 Years

An experimental Novartis AG medicine that killed drug-resistant malaria in laboratory studies may become the first new class of treatment against the disease in 30 years, researchers said.

The drug cured mice at lower doses than existing medicines and killed drug-resistant strains taken from patients in Thailand, researchers said in the journal Science yesterday. Human trials of the drug are planned for this year.